| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2012-09-06 20:58:49 UTC |
|---|
| Update Date | 2022-09-22 18:34:21 UTC |
|---|
| HMDB ID | HMDB0028680 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Alanylalanine |
|---|
| Description | Alanylalanine, also known as AA or ala-ala, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Alanylalanine has been detected, but not quantified in, chives (Allium schoenoprasum). This could make alanylalanine a potential biomarker for the consumption of these foods. Alanylalanine is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a significant number of articles have been published on Alanylalanine. |
|---|
| Structure | C[C@H](N)C(=O)N[C@@H](C)C(O)=O InChI=1S/C6H12N2O3/c1-3(7)5(9)8-4(2)6(10)11/h3-4H,7H2,1-2H3,(H,8,9)(H,10,11)/t3-,4-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| AA | ChEBI | | Ala-ala | ChEBI | | L-Ala-L-ala | ChEBI | | N-L-Alanyl-L-alanine | ChEBI | | Alanylalanine, (D-ala)-(L-ala)-isomer | MeSH, HMDB | | Alanylalanine, (L-ala)-(D-ala)-isomer | MeSH, HMDB | | Dialanine | MeSH, HMDB | | D-Ala-D-ala | MeSH, HMDB | | H-Ala-ala-OH | MeSH, HMDB | | Alanylalanine, (D)-isomer | MeSH, HMDB | | Alanylalanine, (L)-isomer | MeSH, HMDB | | Alanylalanine, (L-ala)-(DL-ala)-isomer | MeSH, HMDB | | Alanylalanine | MeSH | | N-D-Alanyl-L-alanine | MeSH, HMDB | | N-L-Alanyl-D-alanine | MeSH, HMDB | | H-D-Ala-D-ala-OH | MeSH, HMDB | | Alanyl-D-alanine | MeSH, HMDB | | Di-L-alanine | MeSH, HMDB | | D-Alanyl-D-alanine | MeSH, HMDB | | D-Alanylalanine | MeSH, HMDB | | D-Alanyl-L-alanine | MeSH, HMDB | | L-Alanyl-D-alanine | MeSH, HMDB | | A-A dipeptide | HMDB | | AA dipeptide | HMDB | | Alanine alanine dipeptide | HMDB | | Alanine-alanine dipeptide | HMDB | | Alanyl-alanine | HMDB | | L-Alanyl-L-alanine | HMDB | | N-Alanylalanine | HMDB | | NSC 89598 | HMDB | | alpha-Alanylalanine | HMDB | | α-Alanylalanine | HMDB |
|
|---|
| Chemical Formula | C6H12N2O3 |
|---|
| Average Molecular Weight | 160.1711 |
|---|
| Monoisotopic Molecular Weight | 160.08479226 |
|---|
| IUPAC Name | (2S)-2-[(2S)-2-aminopropanamido]propanoic acid |
|---|
| Traditional Name | (2S)-2-[(2S)-2-aminopropanamido]propanoic acid |
|---|
| CAS Registry Number | 1948-31-8 |
|---|
| SMILES | C[C@H](N)C(=O)N[C@@H](C)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C6H12N2O3/c1-3(7)5(9)8-4(2)6(10)11/h3-4H,7H2,1-2H3,(H,8,9)(H,10,11)/t3-,4-/m0/s1 |
|---|
| InChI Key | DEFJQIDDEAULHB-IMJSIDKUSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- N-acyl-alpha-amino acid
- N-acyl-alpha amino acid or derivatives
- N-acyl-l-alpha-amino acid
- Alpha-amino acid amide
- Alanine or derivatives
- Alpha-amino acid or derivatives
- Amino acid or derivatives
- Carboxamide group
- Secondary carboxylic acid amide
- Amino acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Organopnictogen compound
- Primary aliphatic amine
- Organic nitrogen compound
- Carbonyl group
- Primary amine
- Organic oxygen compound
- Amine
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | -3.38 | Extrapolated |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.28 minutes | 32390414 | | Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | -5.9 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.6918 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 8.17 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 330.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 623.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 300.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 52.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 168.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 48.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 275.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 228.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 666.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 607.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 52.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 709.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 178.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 201.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 540.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 463.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 319.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Alanylalanine,1TMS,isomer #1 | C[C@H](N)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 1490.7 | Semi standard non polar | 33892256 | | Alanylalanine,1TMS,isomer #2 | C[C@H](NC(=O)[C@H](C)N[Si](C)(C)C)C(=O)O | 1515.9 | Semi standard non polar | 33892256 | | Alanylalanine,1TMS,isomer #3 | C[C@H](N)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 1526.6 | Semi standard non polar | 33892256 | | Alanylalanine,2TMS,isomer #1 | C[C@H](N[Si](C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 1602.2 | Semi standard non polar | 33892256 | | Alanylalanine,2TMS,isomer #1 | C[C@H](N[Si](C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 1580.9 | Standard non polar | 33892256 | | Alanylalanine,2TMS,isomer #1 | C[C@H](N[Si](C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C | 2116.0 | Standard polar | 33892256 | | Alanylalanine,2TMS,isomer #2 | C[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1531.3 | Semi standard non polar | 33892256 | | Alanylalanine,2TMS,isomer #2 | C[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1655.7 | Standard non polar | 33892256 | | Alanylalanine,2TMS,isomer #2 | C[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 2277.6 | Standard polar | 33892256 | | Alanylalanine,2TMS,isomer #3 | C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 1610.1 | Semi standard non polar | 33892256 | | Alanylalanine,2TMS,isomer #3 | C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 1590.7 | Standard non polar | 33892256 | | Alanylalanine,2TMS,isomer #3 | C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C | 2089.3 | Standard polar | 33892256 | | Alanylalanine,2TMS,isomer #4 | C[C@H](NC(=O)[C@H](C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 1703.9 | Semi standard non polar | 33892256 | | Alanylalanine,2TMS,isomer #4 | C[C@H](NC(=O)[C@H](C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 1623.8 | Standard non polar | 33892256 | | Alanylalanine,2TMS,isomer #4 | C[C@H](NC(=O)[C@H](C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 2410.0 | Standard polar | 33892256 | | Alanylalanine,3TMS,isomer #1 | C[C@H](NC(=O)[C@H](C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1741.1 | Semi standard non polar | 33892256 | | Alanylalanine,3TMS,isomer #1 | C[C@H](NC(=O)[C@H](C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1690.3 | Standard non polar | 33892256 | | Alanylalanine,3TMS,isomer #1 | C[C@H](NC(=O)[C@H](C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1965.0 | Standard polar | 33892256 | | Alanylalanine,3TMS,isomer #2 | C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1627.9 | Semi standard non polar | 33892256 | | Alanylalanine,3TMS,isomer #2 | C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1673.5 | Standard non polar | 33892256 | | Alanylalanine,3TMS,isomer #2 | C[C@H](N[Si](C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1802.2 | Standard polar | 33892256 | | Alanylalanine,3TMS,isomer #3 | C[C@@H](C(=O)O)N(C(=O)[C@H](C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1744.8 | Semi standard non polar | 33892256 | | Alanylalanine,3TMS,isomer #3 | C[C@@H](C(=O)O)N(C(=O)[C@H](C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1730.6 | Standard non polar | 33892256 | | Alanylalanine,3TMS,isomer #3 | C[C@@H](C(=O)O)N(C(=O)[C@H](C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2011.3 | Standard polar | 33892256 | | Alanylalanine,4TMS,isomer #1 | C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1797.9 | Semi standard non polar | 33892256 | | Alanylalanine,4TMS,isomer #1 | C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1805.2 | Standard non polar | 33892256 | | Alanylalanine,4TMS,isomer #1 | C[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 1748.9 | Standard polar | 33892256 | | Alanylalanine,1TBDMS,isomer #1 | C[C@H](N)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 1747.8 | Semi standard non polar | 33892256 | | Alanylalanine,1TBDMS,isomer #2 | C[C@H](NC(=O)[C@H](C)N[Si](C)(C)C(C)(C)C)C(=O)O | 1808.9 | Semi standard non polar | 33892256 | | Alanylalanine,1TBDMS,isomer #3 | C[C@H](N)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 1769.4 | Semi standard non polar | 33892256 | | Alanylalanine,2TBDMS,isomer #1 | C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 2053.5 | Semi standard non polar | 33892256 | | Alanylalanine,2TBDMS,isomer #1 | C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 1998.2 | Standard non polar | 33892256 | | Alanylalanine,2TBDMS,isomer #1 | C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N[C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C | 2239.0 | Standard polar | 33892256 | | Alanylalanine,2TBDMS,isomer #2 | C[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1988.4 | Semi standard non polar | 33892256 | | Alanylalanine,2TBDMS,isomer #2 | C[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2055.2 | Standard non polar | 33892256 | | Alanylalanine,2TBDMS,isomer #2 | C[C@H](N)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2373.4 | Standard polar | 33892256 | | Alanylalanine,2TBDMS,isomer #3 | C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 2088.2 | Semi standard non polar | 33892256 | | Alanylalanine,2TBDMS,isomer #3 | C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 2016.4 | Standard non polar | 33892256 | | Alanylalanine,2TBDMS,isomer #3 | C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O)[Si](C)(C)C(C)(C)C | 2251.2 | Standard polar | 33892256 | | Alanylalanine,2TBDMS,isomer #4 | C[C@H](NC(=O)[C@H](C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2195.0 | Semi standard non polar | 33892256 | | Alanylalanine,2TBDMS,isomer #4 | C[C@H](NC(=O)[C@H](C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2041.8 | Standard non polar | 33892256 | | Alanylalanine,2TBDMS,isomer #4 | C[C@H](NC(=O)[C@H](C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2393.1 | Standard polar | 33892256 | | Alanylalanine,3TBDMS,isomer #1 | C[C@H](NC(=O)[C@H](C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2435.0 | Semi standard non polar | 33892256 | | Alanylalanine,3TBDMS,isomer #1 | C[C@H](NC(=O)[C@H](C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2314.2 | Standard non polar | 33892256 | | Alanylalanine,3TBDMS,isomer #1 | C[C@H](NC(=O)[C@H](C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2263.8 | Standard polar | 33892256 | | Alanylalanine,3TBDMS,isomer #2 | C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2314.6 | Semi standard non polar | 33892256 | | Alanylalanine,3TBDMS,isomer #2 | C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2291.3 | Standard non polar | 33892256 | | Alanylalanine,3TBDMS,isomer #2 | C[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N([C@@H](C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2203.9 | Standard polar | 33892256 | | Alanylalanine,3TBDMS,isomer #3 | C[C@@H](C(=O)O)N(C(=O)[C@H](C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2424.4 | Semi standard non polar | 33892256 | | Alanylalanine,3TBDMS,isomer #3 | C[C@@H](C(=O)O)N(C(=O)[C@H](C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2354.0 | Standard non polar | 33892256 | | Alanylalanine,3TBDMS,isomer #3 | C[C@@H](C(=O)O)N(C(=O)[C@H](C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2308.7 | Standard polar | 33892256 | | Alanylalanine,4TBDMS,isomer #1 | C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2656.0 | Semi standard non polar | 33892256 | | Alanylalanine,4TBDMS,isomer #1 | C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2577.2 | Standard non polar | 33892256 | | Alanylalanine,4TBDMS,isomer #1 | C[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2244.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - Alanylalanine GC-MS (1 TMS) | splash10-0fga-9800000000-0bf53db242afda4f5358 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Alanylalanine GC-MS (2 TMS) | splash10-014i-0900000000-b900eb23a067d3da2dab | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Alanylalanine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Alanylalanine 50V, Negative-QTOF | splash10-0a4i-1900000000-98d9275f2b3eea103b4a | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Alanylalanine 50V, Positive-QTOF | splash10-0006-9100000000-e7365ff586d713020d66 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alanylalanine 10V, Positive-QTOF | splash10-0296-4900000000-20846dc82978c9ddade4 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alanylalanine 20V, Positive-QTOF | splash10-0006-9100000000-1271c8457df1a569480e | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alanylalanine 40V, Positive-QTOF | splash10-006x-9000000000-f584320f1e3633c2e808 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alanylalanine 10V, Negative-QTOF | splash10-0a4i-1900000000-8ed3744b20a8eefee5b6 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alanylalanine 20V, Negative-QTOF | splash10-059i-9600000000-b064bf4d540d9047af3a | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alanylalanine 40V, Negative-QTOF | splash10-00du-9000000000-ea85ea32680736b18092 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alanylalanine 10V, Positive-QTOF | splash10-0006-9100000000-a9556cdd03ea097d9213 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alanylalanine 20V, Positive-QTOF | splash10-0006-9000000000-2cbbf675159b82ddf5e8 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alanylalanine 40V, Positive-QTOF | splash10-0006-9000000000-ac3751498e9cf095d11f | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alanylalanine 10V, Negative-QTOF | splash10-052o-4900000000-aae09911d82d8cfafc1f | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alanylalanine 20V, Negative-QTOF | splash10-000i-9100000000-fcc1d4e4f5652338825f | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alanylalanine 40V, Negative-QTOF | splash10-0006-9000000000-f5f0d3e84942d47714c6 | 2021-10-11 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum |
|
|---|
| Disease References | | Colorectal cancer |
|---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
|---|
| General References | - Cha MH, Kim KS, Suh D, Yoon Y: Effects of genetic polymorphism of uncoupling protein 2 on body fat and calorie restriction-induced changes. Hereditas. 2007 Nov;144(5):222-7. [PubMed:18031357 ]
- Seiderer J, Dambacher J, Leistner D, Tillack C, Glas J, Niess JH, Pfennig S, Jurgens M, Muller-Myhsok B, Goke B, Ochsenkuhn T, Lohse P, Reinecker HC, Brand S: Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease. Clin Immunol. 2008 Apr;127(1):49-55. doi: 10.1016/j.clim.2007.11.016. Epub 2008 Jan 11. [PubMed:18248772 ]
- Wang P, Wesdemiotis C, Kapota C, Ohanessian G: The sodium ion affinities of simple di-, tri-, and tetrapeptides. J Am Soc Mass Spectrom. 2007 Mar;18(3):541-52. Epub 2006 Dec 8. [PubMed:17157529 ]
- Vellaisamy K, Napoleon JV, Venkatachalam R, Manheri MK: Multi-chelation approach towards natural product-like skeletons: one-pot access to a nitrogen-containing tetracyclic framework from AlaAla dipeptide. Chem Commun (Camb). 2010 Dec 28;46(48):9212-4. doi: 10.1039/c0cc03355c. Epub 2010 Oct 28. [PubMed:20981384 ]
- Goptar' IA, Kulemzina IA, Filippova IIu, Lysogorskaia EN, Oksenoit ES, Zhuzhikov DP, Dunaevskii IaE, Belozerskii MA, Elpidina EN: [Properties of post-proline cleaving enzymes from Tenebrio molitor]. Bioorg Khim. 2008 May-Jun;34(3):310-6. [PubMed:18672677 ]
- Mallone R, Nepom GT: Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes. Am J Ther. 2005 Nov-Dec;12(6):534-50. [PubMed:16280647 ]
- Dunbar RC, Steill JD, Polfer NC, Oomens J: Peptide length, steric effects, and ion solvation govern zwitterion stabilization in barium-chelated di- and tripeptides. J Phys Chem B. 2009 Aug 6;113(31):10552-4. doi: 10.1021/jp905060n. [PubMed:19606889 ]
- Smith MW, Tyreman DR, Payne GM, Marshall NJ, Payne JW: Substrate specificity of the periplasmic dipeptide-binding protein from Escherichia coli: experimental basis for the design of peptide prodrugs. Microbiology. 1999 Oct;145 ( Pt 10):2891-901. [PubMed:10537211 ]
|
|---|